Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/04/2008CA2669138A1 Use of 5,6-dimethylxanthenone-4-acetic acid as an antimicrobial agent
12/03/2008EP1997895A1 Family of nucleic sequences and deduced protein sequences having human endogenous retroviral patterns, their flanking sequences and their applications
12/03/2008EP1997823A1 Boronic ester and acid compounds, synthesis and uses
12/03/2008EP1997822A1 Process for the preparation of 2-methyl-4-(4-methylpiperazin-1-yl)-10h-thieno-[2,3-b] [1,5] benzodiazepine dihydrochloride trihydrate, 2-methyl-4-(4-methyl-piperazin-1-yl) -10h-thieno[2,3-b] [1,5] benzodiazepine dihydrochloride trihydrate, pharmaceutical compositions comprising it and its use
12/03/2008EP1997818A2 Quinolinone derivatives and their use to treat pain
12/03/2008EP1997811A2 Indazole, benzoxazole and pyrazolopyridine derivatives as P38 kinase inhibitors
12/03/2008EP1997810A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1997809A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1997807A1 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
12/03/2008EP1997806A1 Pahrmaceutical compositions for prevention and treatment of central nervous system disorders
12/03/2008EP1997805A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/03/2008EP1997804A1 Mmp-13-selective inhibitor
12/03/2008EP1997534A1 Cancer treatment combination therapy comprising vinflunine and trastuzumab
12/03/2008EP1997533A1 Heterocyclic boronic acid compounds, dipeptidyl peptidase IV inhibitors
12/03/2008EP1997513A1 Photodynamic therapy for treating conditions of the eye
12/03/2008EP1997506A1 Use of ck2 inhibitor for the treatment and chemosensibilization of refractory tumors to anticancer drugs
12/03/2008EP1997501A2 Extracts from Ajuga reptans cell lines, their preparation and use
12/03/2008EP1997498A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
12/03/2008EP1997497A2 Compositions and methods for treating a posterior segment of an eye
12/03/2008EP1997496A1 Composition containing riboflavin and sesamins
12/03/2008EP1997495A1 2-phenoxy- and 2-phenylsulfanyl-benzenesulfonamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/03/2008EP1997494A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto
12/03/2008EP1997493A1 Combination of a 5-HT7 receptor ligand and an opioid receptor ligand
12/03/2008EP1997492A1 Method of treatment
12/03/2008EP1997491A1 Method for inhibiting tumor metastasis
12/03/2008EP1997490A1 Oral agent for promoting synthesis of tissue collagen
12/03/2008EP1997489A1 Adamantylglycine derivatives as inhibitors of dipeptidyl peptidase IV for the treatment of diabetes
12/03/2008EP1997488A1 Agent for prevention/treatment of irritable bowel syndrome
12/03/2008EP1997487A1 Product for use in the prevention and treatment of cardiovascular diseases, cancer and chronic inflammatory diseases
12/03/2008EP1997486A1 Therapeutic agent for functional brain disease
12/03/2008EP1997485A1 Pharmaceutical composition comprising meglitinide for prevention of hepatic fibrosis
12/03/2008EP1997484A2 Method of identifying GLP-1 secretagogues
12/03/2008EP1997482A1 A pharmaceutical composition comprising eszopiclone
12/03/2008EP1997479A1 Stabilized amorphous candesartan cilexetil compositions for oral administration
12/03/2008EP1997478A2 Liquid formulations for the prevention and treatment of mucosal diseases and disorders
12/03/2008EP1996707A2 A novel method of protecting islet cells from apoptosis during the donor harvesting process
12/03/2008EP1996701A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2
12/03/2008EP1996700A1 Cancerous disease modifying antibody 141205-05
12/03/2008EP1996604A1 Steroidal compounds as steroid sulphatase inhibitors
12/03/2008EP1996603A1 Lipid a antagonists with anti-septic shock, anti-inflammatory, anti-ischemia and analgesic activity
12/03/2008EP1996596A2 Substituted imidazo(2,1-b)thiazole compounds and their use for producing drugs
12/03/2008EP1996594A2 Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof
12/03/2008EP1996593A2 Pharmaceutically acceptable salts and polymorphic forms
12/03/2008EP1996592A1 Indolopyridines as eg5 kinesin modulators
12/03/2008EP1996588A1 Novel dual action receptors antagonists (dara) at the ati and eta receptors
12/03/2008EP1996587A1 Substituted quinazolines as pde10 inhibitors
12/03/2008EP1996586A1 4-(pyrrolopyridinyl)pyrimidinyl-2-amine derivatives
12/03/2008EP1996585A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/03/2008EP1996584A2 Tropane prodrugs with central nervous system activity
12/03/2008EP1996583A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors)
12/03/2008EP1996582A2 Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-ý2-methyl-4,5-(methylenedioxy) phenylacetyl¨thiophene-3-sulfonamide, sodium salt
12/03/2008EP1996581A1 Novel enantiomerically pure beta-agonists, method for their production and their use as medicaments
12/03/2008EP1996580A2 Pyrrazole derivatives as sigma receptors antagonists
12/03/2008EP1996579A2 Antibiotic compounds
12/03/2008EP1996578A1 Heterobicyclic carboxamides as inhibitors for kinases
12/03/2008EP1996577A1 Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity
12/03/2008EP1996574A1 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
12/03/2008EP1996573A1 4, 5, 6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
12/03/2008EP1996571A2 Tetracyclic steroid derivatives useful as progesterone receptor modulators
12/03/2008EP1996567A2 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
12/03/2008EP1996566A1 Bezothiazol derivatives as beta2 adrenoreceptor agonists
12/03/2008EP1996565A2 Substituted aminothiazole derivatives with anti-hcv activity
12/03/2008EP1996564A1 Dibenzyl amine compounds and derivatives
12/03/2008EP1996563A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
12/03/2008EP1996562A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs
12/03/2008EP1996561A1 Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them
12/03/2008EP1996560A1 Quinazolinones and their use as potassium channels activators
12/03/2008EP1996559A1 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4
12/03/2008EP1996558A1 Heterobicyclic carboxamides as inhibitors for kinases
12/03/2008EP1996556A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
12/03/2008EP1996555A1 Compounds which potentiate ampa receptor and uses thereof in medicine
12/03/2008EP1996554A1 Sigma receptor inhibitors
12/03/2008EP1996553A2 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
12/03/2008EP1996551A2 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them.
12/03/2008EP1996550A2 Carboxyamine compounds and their use in the treatment of hdac dependent diseases
12/03/2008EP1996548A1 Sigma receptor compounds
12/03/2008EP1996546A2 Substituted gamma lactams as prostaglandin ep2 agonists
12/03/2008EP1996545A1 Soluble epoxide hydrolase inhibitors and methods of using same
12/03/2008EP1996542A2 Aliskiren nitrate salt
12/03/2008EP1996541A1 2-(aryloxy)acetamide factor viia inhibitors useful as anticoagulants
12/03/2008EP1996291A2 Use of digitalis-like compounds in the treatment of affective disorders
12/03/2008EP1996243A2 Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices
12/03/2008EP1996233A2 Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions
12/03/2008EP1996215A2 Metabolic regulators and uses thereof
12/03/2008EP1996213A2 Method and compositions for potentiating pharmaceuticals with amino acid based medical foods
12/03/2008EP1996212A2 Compounds from an extract of artemisia and methods for treating disorders
12/03/2008EP1996211A1 Gallium compositions for the treatment of liver cancer and methods of use
12/03/2008EP1996210A2 Oral hygiene products and method of using the same
12/03/2008EP1996209A1 Contraceptive composition
12/03/2008EP1996208A2 Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
12/03/2008EP1996207A1 Compositions comprising chitosan suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome
12/03/2008EP1996206A1 Sensitizing a cell to cancer treatment by modulating the activity of a nucleic acid encoding rps27l protein
12/03/2008EP1996205A2 Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin
12/03/2008EP1996204A1 Topical compositions in the form of an oil-in-water emulsion comprising a pro-penetrating glycol and a steroidal anti-inflammatory drug
12/03/2008EP1996203A1 Topical compositions in the form ofan oil-in-water emulsion comprising a pro-penetrant glycol and a steroidal anti-inflammatory drug
12/03/2008EP1996202A1 Chemical compounds
12/03/2008EP1996201A2 Method of preventing and treating hepatic disease using a2b adenosine receptor antagonists
12/03/2008EP1996200A1 Use of adenine-derived compounds for the treatment of lupus
12/03/2008EP1996199A1 Rapidly dissolving solid oral dosage form for delivery of composition for increasing nitric oxide activity
12/03/2008EP1996198A1 Alkylamine-substituted bicyclic aryl compounds useful as modulators of ppar
1 ... 2968 2969 2970 2971 2972 2973 2974 2975 2976 2977 2978 2979 2980 2981 2982 2983 2984 2985 2986 2987 2988 ... 7860